Nova to Report Q4 & FY 2023 Results on Feb 15; Conference Call Set

Ticker: NVMI · Form: 6-K · Filed: Jan 9, 2024 · CIK: 1109345

Nova LTD. 6-K Filing Summary
FieldDetail
CompanyNova LTD. (NVMI)
Form Type6-K
Filed DateJan 9, 2024
Risk Levellow
Pages3
Reading Time4 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: earnings, financial-reporting, conference-call

TL;DR

**Nova's Q4 and Full Year 2023 earnings drop on Feb 15th, mark your calendars!**

AI Summary

Nova Ltd. (Nasdaq: NVMI) announced on January 9, 2024, that it will release its Fourth Quarter and Full Year 2023 financial results on February 15, 2024. The company will also host a conference call on the same day at 8:30 a.m. Eastern Time to discuss these results. This matters to investors because it sets a clear date for when they can expect to receive crucial financial performance data, which will likely influence the stock's short-term price movement.

Why It Matters

This filing provides investors with the exact date to anticipate Nova's latest financial performance, which is critical for evaluating the company's health and making informed investment decisions.

Risk Assessment

Risk Level: low — This filing is a routine announcement of an earnings release date, which carries minimal inherent risk.

Analyst Insight

A smart investor would mark February 15th on their calendar, prepare to review Nova's Q4 and Full Year 2023 financial results, and listen to the conference call to understand the company's performance and outlook before making any significant investment decisions.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What specific financial results will Nova Ltd. be reporting?

Nova Ltd. will be reporting its Fourth Quarter and Full Year 2023 financial results.

When is the conference call scheduled to discuss these financial results?

The conference call is scheduled for February 15, 2024, at 8:30 a.m. Eastern Time.

Who is the Chief Financial Officer of Nova Ltd. mentioned in the filing?

Dror David is the Chief Financial Officer of Nova Ltd. and signed the report.

What is the contact information for investor relations for Nova Ltd.?

The investor relations contact is Miri Segal of MS-IR LLC, reachable at Tel: +917-607-8654 or E-mail: msegal@ms-ir.com.

What is Nova Ltd.'s Nasdaq ticker symbol?

Nova Ltd.'s Nasdaq ticker symbol is NVMI.

Filing Stats: 1,028 words · 4 min read · ~3 pages · Grade level 14.1 · Accepted 2024-01-09 08:00:05

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: January 9, 2024 NOVA LTD. (Registrant) By: /s/ Dror David —————————————— Dror David Chief Financial Officer Company Contact: Dror David, Chief Financial Officer Tel: +972-73-229-5760 E-mail: investors@novami.com Nova Website Link - https://www.novami.com/ Investor Relations Contact: Miri Segal MS-IR LLC Tel: +917-607-8654 E-mail: msegal@ms-ir.com Nova to Report Fourth Quarter and Full Year 2023 Financial Results on February 15 Conference call to be held on the same day at 8:30 a.m. Eastern Time Rehovot, Israel, January 9, 2024 – Nova (Nasdaq: NVMI) , a leading innovator and a key provider of metrology solutions for advanced process control used in semiconductor manufacturing, today announced that it expects to release its financial results for the fourth quarter and full year of 2023 before the Nasdaq market opens on Thursday, February 15, 2024. Q4 and Full Year 2023 Conference Call Details: Gaby Waisman, President and Chief Executive Officer, and Dror David, Chief Financial Officer, will host a conference call to review the Company's fourth quarter and full year 2023 financial results on February 15, 2024 at 8:30 a.m. Eastern Time. To attend the conference call, please dial one of the following numbers at least five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number. U.S. TOLL-FREE : 1-833-816-1427 ISRAEL TOLL-FREE : 1-80-9213284 INTERNATIONAL : 1-412-317-0519 WEBCAST LINK : https://event.choruscall.com/mediaframe/webcast.html?webcastid=XbNPrv6u At: 8:30 a.m. Eastern Time 5:30 a.m. Pacific Time 3:30 p.m. Israel Time The conference call will also be available via a live webcast from a link on Nova's Investor Relations website - https://w

Forward-Looking Statements

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied in those forward-looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: political, economic and military instability in Israel, including related to the recent attack by Hamas and other terrorist organizations from the Gaza Strip and Israel's war against them; increased information technology security threats and sophisticated computer crime; foreign political and economic risks including supply-chain difficulties; regulations that could restrict our operations such as economic sanctions and export restrictions; changes in U.S. trade policies; indirect effects of the Russia – Ukraine conflict; market instability including inflation and recessionary pressures; risks related to doing business with China; catastrophic events such as the outbreak of COVID-19; inability to protect our intellectual property; open source technology exposure; failure to compete effectively or to respond to rapid technological changes; consolidation in our industry; difficulty in predicting the length and strength of any downturn or expansion period of the market we target; factors that adversely affect the pricing and demand for our product lines; dependency on a small number of large customers; dependency on a si

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing